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Abstract:  
 This thesis explores the role of glucocorticoids in entraining the rhythmicity of clock 
gene expression in components of the hypothalamic-pituitary-adrenal (HPA) axis, specifically 
the paraventricular nucleus (PVN) of the hypothalamus and the anterior pituitary. Physiological 
and behavioral circadian rhythms rely on molecular oscillators inside cells of living organisms. 
Rhythmic expression of associated clock genes is dependent on the hypothalamic 
suprachiasmatic nucleus (SCN), which is synchronized to the light/dark cycle with an intrinsic 
rhythm near 24 hours. Extra-SCN brain regions and peripheral tissues in the body have been 
shown to have molecular clocks; interestingly, the SCN has sparse direct neural input in these 
regions. Previous research has indicated that glucocorticoids (CORT) are able to entrain clock 
gene rhythmicity in peripheral tissues, suggesting the SCN may synchronize peripheral clocks 
through a diurnal expression of CORT. Little work has been done to explore this possible 
mechanism of entrainment in the brain but has been characterized in periphery where CORT has 
been shown to cause a phase shift, induce, or abolish clock gene expression in tissues such as 
liver and kidney. This thesis characterizes clock gene expression in response to three different 
CORT profiles: antiphasic CORT treated, phasic CORT treated, and vehicle treated in 
adrenalectomized rats. We found that expression of clock genes Per1 and Per2 varied with 
CORT treatment in both the PVN and anterior pituitary, but also that CORT influenced genes 
differently in the two regions. The results suggest that CORT may have a permissive effect in the 
periphery, necessary for clock gene expression, but has an entraining effect in the brain. This 
study was an important step in understanding the role of CORT in HPA axis regulation and 
disruption. Such disruptions and dysregulation of the HPA have been observed in numerous 
conditions such as Posttraumatic Stress Disorder, Major Depressive Disorder, and sleep 
disorders. 
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Introduction:  
 The hypothalamus plays central roles in both the diurnal and stress systems. The diurnal 
system refers to the 24 hour cycle living organisms have functionally evolved to. Virtually all 
organisms express an internal clock system; the molecular read out of this clock can be found 
almost ubiquitously in tissue (Takahashi et al., 2008; Ko and Takahashi, 2006). These rhythms 
create an internal circadian rhythm under the influence of the light/dark cycle. The master clock 
is housed within the suprachiasmatic nucleus (SCN) of the hypothalamus; its primary input is 
light/dark information transferred from the retina to the hypothalamus via the retinohypothalamic 
tract, and is responsible for integrating light cues from the environment. 
The stress system, also centrally controlled by the hypothalamus, helps organisms to 
adapt to aversive changes and stressors.  Organisms’ hormonal responses to aversive changes are 
controlled by the paraventricular nucleus (PVN) of the hypothalamus, the head of the 
hypothalamic-pituitary-adrenal (HPA) axis (Meerlo et al., 2002). The full HPA axis consists of 
parvocellular corticotropin-releasing-hormone (CRH) and arginine vasopressin (AVP)-secreting 
cells in the PVN, the adrenocorticotropic hormone (ACTH) secreting pituitary corticotrophs, and 
the glucocorticoids (CORT) released from the cortex of the adrenal gland. CORT is the final 
effector of the HPA axis’ hormonal cascade. Receptors of CORT, glucocorticoid receptors (GR), 
are ubiquitously expressed in the body, facilitating the hormones wide spread influences. The 
stress system reestablishes homeostasis by regulating physiological activities including 
intermediary metabolism, immunity, and reproduction (Chrousos, 2009; Churousos and Kino, 
2007). It also suppresses the PVN and pituitary gland in a closed negative feedback loop. 
Important to note, are the adverse effects hyperactivation of the HPA axis can have, such as 
Posttraumatic Stress Disorder, while chronic activation of the HPA axis and prolonged elevation 
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of CORT may induce obesity and insulin resistance (Chrousos, 2009; Churousos and Kino, 
2007).  
Without the influence of stress stimulation ACTH, a pituitary hormone released in 
response to CRH, and CORT show diurnal rhythmic activity, with plasma levels peaking in 
anticipation of the organism’s active period. The SCN is primarily responsible for the cyclic, 
baseline functioning of the HPA axis (Fahrenkrug et al., 2008).  
It is not just the diurnal activity of the HPA axis the SCN controls, it is also responsible 
for synchronizing the clocks in the extra-SCN brain and body (Girotti et al., 2009). The 
molecular mechanism for circadian rhythms, physiological and behavioral, depends on the 
oscillatory expression and autoregulation of clock genes. These rhythmically expressed clock 
genes have been characterized in the SCN, extra-SCN brain, and peripheral tissues (Amir and 
Stewart, 2009; Guilding and Piggins, 2007; Feillet et al., 2008) such as the pancreas, thymus, and 
lungs (Saper et al., 2005). Among the core clock genes are positive regulators, circadian 
locomotor output cycle kaput (Clock) and brain and muscle aryl hydrocarbon receptor nuclear 
traslocator-like (Bmal), which in turn induce the expression of their own negative regulators, the 
Period (Per1, Per2, Per3) and Cryptochrome (Cry1, Cry2) genes. CLOCK/BMAL1 proteins 
form a heterodimer which binds the E-box response elements located in the promoter region, 
stimulating the transcription of the negative regulating clock genes. PER and CRY proteins 
accumulate as dimers in the cytoplasm, which repress CLOCK/BMAL1 heterodimerization and 
subsequent induction of their own promoters (Kondratov et al. 2006). The time course for this 
standard negative feedback loop is 24 hours (Kiyohara et al., 2006).  
These clock genes, while expressed in virtually all cells with an intrinsic rhythm near 24 
hours, rely on normal SCN functioning to synchronize phasic expression with the light/dark 
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cycle. Interestingly, direct SCN innervation is sparse in extra-SCN tissues; the lack of direct 
input suggests an alternative mechanism of control. While the SCN lacks significant direct 
innervation of most extra-SCN tissue, GRs are ubiquitously expressed in every cell in the body 
with the noted exception of the SCN itself. Several studies have shown CORT plays a crucial 
role in regulating diurnal rhythms in peripheral tissue (Balsabore et al., 2000) and entraining 
autonomic clocks (Horseman and Ehret, 1982), in establishing and maintaining circadian 
behavioral patterns (Sage et al., 2004), and molecular circadian rhythms (Balsaobre et al., 2000; 
Pezuk et al., 2012).  
The absence of GRs in the SCN leaves the master clock mostly unaffected by CORT 
fluctuations. The lack of GR in the SCN coupled with the SCN’s control of the HPA axis, and 
therefore CORT release, is a potential mechanism where CORT is used to synchronize the 
peripheral clocks. Disrupting circadian CORT secretion can cause a phase-shift in clock gene 
expression in the periphery (Bur et al., 2010; Segall and Amir, 2010). GR acts as a transcription 
factor for numerous genes, significantly the canonical core clock gene Period1 (Per1) which 
includes a sensitive glucocorticoid-response element (GRE) in its promoter region (Yamamoto et 
al., 2005). The GRs action as a transcription factor is a possible way glucocorticoids entrain 
peripheral clocks, especially for genes with a functional GRE in the promoter region as they may 
be induced by diurnal CORT and sensitive to disruptions in the normal expression of CORT.  
While the effect of disrupted CORT on clock gene expression has been characterized in 
the periphery, little research has been done on characterizing clock gene expression and CORT-
dependent influence within the HPA axis itself. Understanding the rhythmic expression of clock 
genes within the HPA axis, a potential regulatory mechanism for circadian rhythms, is essential 
as research on circadian rhythms expands into non-SCN areas of the brain. The wide spread 
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presence of rhythmically expressed clock genes in peripheral tissue and extra-SCN brain 
suggests functional relevance. In genetically mutant mice with knockdown of certain core clock 
genes present a range of behavioral phenotypes associated with impaired cognition and 
emotional function (Takahashi et al., 2008; Garcia et al., 2000; McClung, 2007). As well, 
interference in the rhythmic, baseline function of the HPA axis has been implicated in several 
diseases such as Major Depressive Disorder and sleep disorders insomnia and sleep apnea 
(Pariante and Miller, 2001; Buckley and Schatzberg, 2005; Gold et al., 1988). 
The purpose of this thesis is to explore the extent to which glucocorticoids (CORT) 
regulate clock gene expression in the anatomical components of the HPA axis. In this study, we 
investigated the effect of three CORT profiles—antiphasic to the endogenous peak of CORT, in 
the early morning in nocturnal rodents; phasic CORT, where CORT was injected in the evening 
at the onset of the active period and normal peak time of endogenous CORT; and vehicle 
injected groups—on the rhythmic expression of core clock genes Bmal1, Per1, Per2 in the SCN, 
PVN, and anterior pituitary of adrenalectomized male rats. Adrenals were surgical removed from 
rats to remove endogenous, circulating CORT to test the necessity of the hormone for rhythmic 
expression of clock genes. Injection times, AM and PM, were chose based on the diurnal rhythm 
of CORT in adrenal intact rats; CORT peaks at the onset of the dark, active period in rats and 
reaches its trough in the morning. The AM injection acts in opposition to input from the SCN 
allowing us to investigate if the influence of CORT can override photoperiod information. Core 
clock genes Bmal1, Per1, and Per2 were selected as they are the positive and negative arms, 
respectively, of the molecular clock. As well, Per1 has been characterized with a hyperactive 
GRE. It’s also been suggested that Per2 has a GRE (So et al., 2009); our lab has also 
demonstrated in the past that Per2 is more rhythmically expressed in the anterior pituitary 
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(Girotti et al., 2009). The intermediate pituitary expresses no GRs and is vestigial in humans; the 
posterior pituitary consists mostly of magnocellular axons. As well these other regions are not 
central to the function of the HPA axis stress system. For these reasons they were not included in 
this examination. It is important to address that adrenalectomy removed the final component of 
the HPA axis from our experiment. However, the adrenals have been shown to have an 
autonomous molecular clock that is not sensitive to fluctuations in CORT because of saturation, 
making present GR’s functional insignificant (Son et al., 2008).  
Given that there are no GRs in the SCN, it is unlikely that there will be an effect of 
CORT status on clock gene expression within the nucleus. Based on preliminary research in our 
lab, Bmal1 expression in the PVN will not be influenced, but Per1 expression, given its 
sensitivity to CORT, may display a blunted amplitude due to antiphasic CORT treatment 
(Woodruff, Fardi & Spencer 2013, unpublished data). Studies of the pituitary have provided 
varied results. While Bmal1 has been repeatedly shown as rhythmic, Per1 rhythmicity is varied 
based on experimental conditions (Bur et al., 2010; Girotti et al., 2009). We anticipate that 
antiphasic CORT treatment would disrupt the normal expression of Per1, but based on past 
observations of gene expression in the PVN, rats treated with phasic (PM) CORT and vehicle 
would display rhythmicity. Per2 expression, however, has been shown to be rhythmic except in 
instances where feeding was disrupted (Bur et al., 2010; Girotti et al., 2009). Given these results 
and the presence of continuously occupied GRE by dimerized GR in the promoter region of Per2 
(So et al., 2009), we expect Per2 gene expression to by rhythmic in both CORT treated groups, 
possibly with a difference in phases between AM and PM injected groups, but not in the vehicle 
group.  
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Materials and Methods:  
Animals  
 Male Sprague-Dawley rats (250-280g; Harlan Laboratories, Indianapolis, IN) were given 
a 2-week acclimation period prior to surgery. Rats were housed two per cage (polycarbonate 
tubs, 47 cm x 23 cm x 20 cm), given food (Teklad Rodent Diet 8640; Harlan) and water pre-
adrenalectomy, 0.9% saline post-adrenalectomy, ad libitum. All rats were maintained on a 12:12-
h light/dark cycle. Experimental procedures were approved and adhered to the guidelines put 
forth by the University of Colorado Institutional Animal Care and Use Committee.  
Surgery 
 Bilateral adrenalectomy was performed on all rats. Halothane was used to anesthetize 
animals during surgery. Incisions were made bilaterally through the skin and peritoneal wall near 
the kidney; adrenal glands of all rats were removed. Following surgery, rats were given a 2-day 
recovery period before administration of injections. Adrenalectomized rats were given 0.9% 
saline water ad libitum.  
Injections  
 After the post-surgery recovery period, all rats received a 0.3 ml intraperitoneal (i.p) 
injection of either vehicle (60% saline, 30% propylene glycol, 10% ethanol) or 2.5 mg/kg CORT 
(Steraloids, Newport, RI). Injections were administered daily for 13 days. The adrenalectomized 
rats were divided into four treatment groups: CORT AM which received a CORT injection at 
Zeitgeber Time (ZT) 1, one hour after lights on, CORT PM which received a CORT injection at 
ZT 11, one hour before lights off, and Vehicle groups which received injections either at ZT 1 or 
ZT 11 (Fig. 1).  
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Experimental Procedure 
 Following 13 days of 
consecutive injections, groups of rats 
(for CORT-injected groups: n=6; for 
vehicle-injected: n=4; total number of 
animals: N=80), were decapitated at 
four time points [ZT 0 (lights on), ZT 
6 (6 hours after lights on), ZT 12 
(lights off), and ZT 18 (6 hours after 
lights off), Fig. 1]. To avoid acute 
effects of transitioning between lights on/off,  decapitations for ZT 0 and ZT 12 were performed 
approximately 15 minutes prior to the target times. Brains and pituitaries were extracted and 
flash-frozen in a dry-ice isopentane at -30˚C. Collected tissue was later stored at -80˚C. 
In Situ Hybridization and Image Analysis  
 Using a Leica Microsystems cryostat (model 1850, Bannockburn, IL USA) coronal brain 
slices (12 µm) were collected from the suprachiasmatic nucleus (SCN) and paraventricular 
nucleus of the hypothalamus (PVN) [~1.30 and 1.80 mm posterior to bregma] or transversely (12 
µm) through the middle  of the pituitaries. Tissue was thaw mounted on Superfrost Plus slides 
(Fisher Scientific, Pittsburgh, PA) and stored at -80˚C.  
 In situ hybridization for Bmal1, Per1, and Per2 mRNA and analysis of digitized X-ray 
films were performed as previously described (Girotti et al. 2009), with some provisions that 
should be noted. Slides were fixed 4% paraformaldehyde, washed in 2X saline-sodium citrate 
buffer, and treated with triethanolamine (TEA). Acetic anhydride was added to the TEA to 
Figure 1:  
Experimental design. 
A: a timeline of the 
experiment. B: 24 
hour experimental 
design. Red text 
denotes ZT of 
sacrifice (ZT0, ZT6, 
ZT12, ZT18). 
Needles mark the 
times injections were 
administered [ZT1 
(AM injection, one 
hour after lights on) 
and ZT11 (PM 
injection, one hour 
before lights off).  
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decrease background and strengthen signal specificity by inactivating ribonucleases. Following 
this treatment, slides were dehydrated in graded ethanol washes (50%, 75%, 95%, 95%, 100%, 
and 100%) and allowed to air dry. Slides were then cover-slipped with 65µl of radioactive 
hybridization buffer, which contains a riboprobe made early in the day through a series of 37˚C 
incubations and separated using a G50/50 sephadex column. This applied ~1.5x10
6
 cpm of 
radioactivity per slide. The 
35
S-UTP labeled antisense probes were generated within the lab using 
transcription-buffer, DNASE, T7 (Per1 and Per2 RNA polymerase) and T3 (Bmal1 polymerase) 
polymerases, and GCA nucleotide (PROMEGA, Madison, WI, USA). The identity of the DNA 
was verified by DNA sequencing (University of Colorado Boulder Molecular Cellular and 
Developmental Biology sequencing facility).  
Radioactive slides were exposed to film for 2 or 3 weeks depending on signal strength 
before developed (auto-developer, Konica Minolta Medical and Graphic, Inc). Tissue film was 
digitized using Scion Image (Scion Corporation). Images were analyzed at the level of SCN, 
PVN, and anterior pituitary; brain regions of interest were determined using rat brain atlas 
(Paxinos and Watson, 1998). Optical density was performed with Image J (NIH analysis 
software) on eight sections were averaged per subject. Measurements were made within regions 
of interest with a standardized size.  Examples of in situ hybridization signals at peak expression 
levels for each gene tested in various tissues are presented in Figure 2.  
Statistical Analysis  
 Diurnal changes of hormone secretion and clock gene expression were fitted to a basic 
cosinusoid function {yi=M + A cos (ωti + ϕ) + ei i=1,…, N; where M is the MESOR, A is 
amplitude, ω is frequency, t is time, and ϕ is acrophase}. Acrophase, confidence interval, and 
time of decapitation were expressed as ZT. The program Chronolab was used to estimate the 
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parameters of best fit for each treatment group with 95% confidence intervals. To examine the 
primary effects and interactions of time of day and CORT status, two way ANOVAs were 
performed. It is important to note that the ZT 1 and ZT 11 vehicle injected groups were 
combined into one (“Vehicle”) as there was not a significant difference in the clock gene 
expression data between the two groups. Post hoc pairwise comparisons (Fisher’s least-
significant difference) were examined only in instances where the ANOVA yielded a significant 
interaction between time of day and CORT status. SPSS (Statistical Package for the Social 
Sciences) was used in these analyses and a p<0.05 was deemed significant.  
 
 
 
 
 
 
 
 
 
 
 
Results: 
Suprachiasmatic Nucleus (SCN):  
Bmal1 mRNA expression in all treatment groups showed a significant 24 hour rhythm 
(p<0.001) with peaks in the early dark phase (acrophase: ZT12.31, confidence interval: 11.1-13.5 
for AM CORT; acrophase: ZT12.53, confidence interval: 11.4-13.7 for PM CORT; acrophase: 
Figure 2: Representative 
audioradiogram images from  
Bmal1 , Per1, Per2  in PM 
CORT  rats, images selected 
to closest peak ZT times. 
Regions of interest are within 
the red circle on the coronal 
brain images. SCN (A-C): 
Bmal1 peak at ZT 12. Per1 
peak at ZT6 and Per2 peak at 
ZT12. PVN(D-F): Bmal1 
peak at ZT0. Per1 peak at 
ZT6 and Per2 peak at ZT18. 
Anterior Pituitary (G-I): 
Bmal1 peak at ZT18. Per1 
and Per2 peak at ZT 12. 
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ZT13.28, confidence interval: 12.1-14.5 for Vehicle; Table 1). The rhythms presented with 
similar mesor (M) values (M= 130.54 AM CORT; M=133.72 PM CORT; M=137.95 for 
Vehicle; Table 1). There was a significant time of day effect (F(3,77)=52.83, p<0.001) but no 
CORT effect. A significant interaction was found between the two factors (F(6,77)=2.84, p=.016), 
and while posthoc analysis revealed significant difference at ZT12 in AM CORT Bmal1 
expression when compared to PM CORT (p=0.025). Likely, this difference is not functionally 
relevant as the amplitudes of all treatment groups overlap (amplitude: 43.34, confidence interval: 
30.5-56.2 for AM CORT; amplitude: 30.91, confidence interval: 21.7-40.1 for Vehicle; 
amplitude: 30.83, confidence interval: 21.6-40.1 for PM CORT) (Fig. 3A).  
Per1 mRNA expression displayed a significant 24 hour rhythm for all CORT statuses 
(p<0.001) with acrophases in the light phase (acrophase: ZT4.13, confidence interval: 3.3-5 for 
AM CORT; acrophase: ZT4.52, confidence interval: 3.7-5.3 for PM CORT; acrophase: ZT3.72, 
confidence interval 3.3-4.1 for Vehicle; Table 1). The mesor values were similar despite CORT 
status (M=87.57 for AM CORT; M=84 for PM CORT; M=82.47 for Vehicles; Table 1). There 
was a significant time of day effect (F(3,77)=165.19, p<0.001) but no CORT effect. As with 
Bmal1, there was a significant interaction between the two factors (F(6,77)=2.86, p=.015), with a 
difference in expression at ZT12 of the vehicle group (p=0.038) compared to PM CORT. Likely, 
there is no functional relevance as the confidence intervals of AM CORT and Vehicle treated 
groups’ amplitudes overlap with that of PM CORT (amplitude: 29.21, confidence interval: 22.8-
35.6 for AM CORT; amplitude: 40.53, confidence interval 36.2-44.9 for Vehicle; amplitude: 
35.08, confidence interval: 27.7-42.5 for PM CORT) (Fig. 3B).  
Regardless of CORT status, Per2 mRNA was expressed with significant 24 hour rhythms 
(p=0.005 for AM CORT; p<0.001 for PM CORT; p=0.022 for Vehicle). Peak mRNA expression 
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occurred in the light phase (acrophase: ZT7.82, confidence interval 7.3-8.2 for AM CORT; 
acrophase: ZT8.1, confidence interval 7.5-8.7 for PM CORT; acrophase: ZT8.45, confidence 
interval 7.9-9.1; Table 1). All treatment groups presented with similar mesor values (M=150.89 
for AM CORT; M=150.14 for PM CORT; M=151.97 for Vehicle; Table 1). Time of day had a 
significant effect (F(3,77)=194.41, p<0.001), but there was no CORT effect or interaction between 
the two factors (Fig. 3C).  
Paraventricular Nucleus (PVN):  
 Bmal1 mRNA expression displayed significant 24 hour rhythms for all treatment groups 
(p<0.001) with peaks occurring in the early light phase (acrophase: ZT0.68, confidence interval 
23.5-1.9 for AM CORT; acrophase: ZT1.87, confidence interval 0.6-3.1 for PM CORT; 
acrophase: ZT0.87, confidence interval 23.5-2.2 for Vehicle; Table 1), antiphasic to the 
expression profile of Bmal1 in the SCN. Mesor values were similar for all treatment groups 
(M=65.27 for AM CORT; M=69.91 for PM CORT; M=63.76 for Vehicle; Table 1). There was a 
significant time of day effect (F(3,77)=73.65, p<0.001), but no CORT effect and no interaction 
between factors (Fig. 3D).  
 Expression of Per1 mRNA displayed significant 24 hour rhythms regardless of CORT 
status (p<0.001) with acrophases in the early dark phase (acrophase: ZT13.62, confidence 
interval 12.1-12.6 for AM CORT; acrophase: ZT13.33, confidence interval 12.3-14.4 for PM 
CORT; acrophase: ZT12.55, confidence interval 11.5-13.6 for Vehicle; Table 1). Importantly, 
per1 expression in the PVN is antiphasic to its SCN counterpart which demonstrates the PVN’s 
responsiveness to different input than photoperiod, here the rat’s nocturnal activity pattern. All 
treatment groups presented with similar mesor values, though there is lower average mRNA 
expression of Per1 mRNA in the antiphasic treated group likely as a result of blunted amplitude 
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(M=120.1 for AM CORT; M=136.09 for PM CORT; M=131.15 for Vehicle; Table 1). There 
was a significant time of day effect (F(3,77)=78.92, p<0.001) and CORT effect (F(2,76)=5.21, 
p=0.008), and interaction between the two (F(6,77)=5.7, p<0.001). This effect can be seen in the 
blunting of per1 expression in antiphasic treated animals compared to the PM CORT group at 
ZT12 (p<0.001) (Fig. 3E).  
 Per2 mRNA expression was expressed with significant 24 hour rhythms regardless of 
CORT status (p=0.002 for AM CORT; p<0.002 for PM CORT and Vehicle). Acrophases for all 
treatment groups occurred in the dark phase (acrophase: ZT18.61, confidence interval 16.6-20.6 
for AM CORT; acrophase: ZT15.56, confidence interval 14.5-16.6 for PM CORT; acrophase: 
ZT15.46, confidence interval 14.7-16.2 for Vehicle; Table 1). It is important to note that there is 
a shift in the Per2 mRNA expression further into the dark phase and is not truly antiphasic to its 
SCN counterpart. Mesor values for PM CORT and Vehicle groups were similar, while average 
expression of Per2 mRNA in the antiphasic group was lower, a likely result of blunted amplitude 
(M=119.98 for AM CORT; M=132.45 for PM CORT; M=128.94 for Vehicle; Table 1). There 
was a significant time of day effect (F(3,75)=194.41, p<0.001), no CORT effect, but interaction 
between the two factors (F(6,75)=4.55, p=0.001). This effect manifested as blunted Per2 mRNA 
expression at ZT12 in the antiphasic CORT treated group compared to PM CORT (p<0.001) 
(Fig. 3F).  
Anterior Pituitary:  
Bmal1 mRNA expression was shown to have a significant 24 hour rhythm in all 
treatment groups (p<0.001). All three groups had peak values which occurred in the dark period 
regardless of CORT status (acrophase: ZT 19.79, confidence interval: 18.9-22.5 for AM CORT; 
acrophase: ZT 21.85, confidence interval: 19.0-20.3 for PM CORT; acrophase: ZT 20.73, 
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confidence interval: 18.9-22.5 for Vehicle; Table 1), in sync with Bmal1 mRNA expression in 
the PVN. The mesor values of treatment groups were similar (M=77.61 for AM CORT; M=74.5 
for PM CORT; M=68.36 for Vehicle; Table 1). While there was a significant time of day effect 
(F(3,79)=28.05, p<0.001) there was no significant effect of CORT status or interaction between the 
two factors (Fig. 3G).  
In both AM and PM CORT groups, Per1 mRNA presented with significant rhythmicity 
(p=0.036 for AM CORT; p=.006 for PM CORT). Despite visual appearance, the Vehicle group 
did not have a significant 24 hour rhythm. Both AM and PM CORT groups peaked near the end 
of the light period (acrophase: ZT 9.29, confidence interval: 6.1-12.5 for AM CORT; acrophase: 
ZT 10.48, confidence interval: 8.1-12.7 for PM CORT; Table 1). This expression pattern of Per1 
mRNA is similar to that displayed in the PVN. Treatment groups displayed similar mesor values 
(M=87.57 for AM CORT; M=84 for PM CORT; M=82.47 for Vehicle; Table 1). Similarly to 
Bmal1 expression, there was a significant time of day effect (F(3,79)=6.27, p=0.001) but no 
significant effect of CORT status or interaction between factors. This may be because, despite a 
lack of rhythmicity in Vehicle group, Per1 mRNA expression has amplitude similar to other 
treatment groups (Fig. 3H). 
 Per2 mRNA expression had a significant 24 hour rhythm in all treatment groups 
(p=0.005 for AM CORT; p<0.001 for PM CORT; p=0.022 for Vehicle). It is important to note 
that while the Vehicle group was rhythmic its amplitude was significantly blunted (amplitude: 
6.89, confidence interval: 2.1-11.7 for Vehicle compared to amplitude: 56.75, confidence 
interval: 25.0-88.5 for AM CORT and amplitude: 48.44, confidence interval 31.6-65.2 for PM 
CORT; Table 1). Similar to Per1 mRNA, Per2 mRNA expression in all groups tended to peak in 
the hours prior to the dark period (acrophase: ZT 9.65, confidence interval: 7.3-11.9 for AM 
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CORT; acrophase: ZT 9.56, confidence interval: 8.2-10.9 for PM CORT; acrophase: ZT 12.00, 
confidence interval: 9.2-14.8 for Vehicle; Table 1), phasic to Per2 expression in the PVN. The 
mesor value of the AM CORT group is elevated compared to both PM CORT and Vehicle 
groups (M=178.36 for AM CORT; M=120.22 for PM CORT; M=83.94; Table 1). There was a 
significant interaction between time of day and CORT status (F(6,77)=6.37, p<0.001). This was 
seen in the Vehicle group’s blunted amplitude, such that Per2 mRNA expression was lower at 
ZT 6 (p=0.009) and ZT 12 (p<0.001) compared to PM CORT (Fig. 3I).  
It is important to note that rhythmicity of Per1 and Per2 are antiphasic to Bmal1 both 
within the PVN and anterior pituitary and in comparison to the SCN.  
 
 
 
 
  
 
 
Figure 3: Temporal patterns of clock gene expression in SCN and individual components of the HPA axis. Levels of Bmal1, Per1, Per2 mRNAs 
were determined by in situ hybridization in the SCN (A-C), PVN (D-F), and anterior pituitary (G-I). The ZT 0 time point was plotted twice (ZT 
0 and ZT 24) for graphical visualization. The period of lights off is denoted by a dark bar above the x-axis. The blue line represents the PM CORT 
group, red line represents the Vehicle group, and the green represents the AM CORT group. * denotes significant rhythmicity p<0.05. ** denotes 
significant rhythmicity p<0.001. + denotes Fisher’s Least Square Difference (FLSD) significance p<0.05. ++ denotes FLSD significance p<0.001. 
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Table 1:  
Measure Treatment Group PR p-value Mesor ф Confidence Interval 
Bmal1 
SCN 
CORT AM 70.1 <0.001 130.54 12.30666667 11.1-13.5 
CORT PM 69.7 <0.001 133.72 12.52666667 11.4-13.7 
Vehicle AM/PM 62.8 <0.001 137.95 13.28 12.1-14.5 
PVN 
CORT AM 67.3 <0.001 65.27 0.68 23.5-1.9 
CORT PM 66.2 <0.001 69.91 1.873333333 0.6-3.1 
Vehicle AM/PM 62.4 <0.001 63.76 0.873333333 23.5-2.2 
Anterior 
Pituitary 
CORT AM 73.3 <0.001 77.61 19.79333333 18.9-22.5 
CORT PM 65.2 <0.001 74.5 21.84666667 19.0-20.3 
Vehicle AM/PM 39.1 <0.001 68.36 20.73333333 18.9-22.5 
Per1 
SCN 
CORT AM 82.1 <0.001 87.57 4.133333333 3.3-5 
CORT PM 82.1 <0.001 84 4.52 3.7-5.3 
Vehicle AM/PM 92.7 <0.001 82.47 3.72 3.3-4.1 
PVN 
CORT AM 59 <0.001 120.09 13.62 12.1-12.6 
CORT PM 72.5 <0.001 136.09 13.32666667 12.3-14.4 
Vehicle AM/PM 66 <0.001 131.15 12.55333333 11.5-13.6 
Anterior 
Pituitary 
CORT AM 27.1 0.036 181.92 9.293333333 6.1-12.5 
CORT PM 38.3 0.006 155.51 10.48 8.1-12.7 
Vehicle AM/PM 9.2 0.224 177.34 13.28666667 -- 
Per2 
SCN 
CORT AM 93.3 <0.001 150.89 7.82 7.3-8.2 
CORT PM 90.9 0.001 150.14 8.1 7.5-8.7 
Vehicle AM/PM 85.5 <0.001 151.97 8.446666667 7.9-9.1 
PVN 
CORT AM 44.9 0.002 119.89 18.61333333 16.6-20.6 
CORT PM 74.4 <0.001 132.45 15.56 14.5-16.6 
Vehicle AM/PM 81.6 <0.001 128.94 15.46 14.7-16.2 
Anterior 
Pituitary 
CORT AM 41 0.005 178.36 9.653333333 7.3-11.9 
CORT PM 63.2 <0.001 120.22 9.56 8.2-10.9 
Vehicle AM/PM 21.9 0.022 83.94 12.00666667 9.2-14.8 
 
 
Table 1: Estimates of measured acrophase (ϕ) for Bmal1, Per1, and Per2 mRNA in the SCN, PVN, and anterior 
pituitary are summarized above. Associated confidence intervals (C.I.) are given only where rhythmicity was significant. 
Percent rhythm (PR), p values, and mesor values are also listed. Estimated acrophases and C.I. are given as ZT.   
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Discussion: 
Clock Gene Expression in the SCN: 
 In this study we investigated the influence of three CORT profiles (no CORT, antiphasic 
AM CORT, and phasic PM CORT) on the molecular clocks in the PVN and anterior pituitary, as 
well as the SCN. Core clock genes Bmal1, Per1, and Per2 mRNA exhibited rhythmic expression 
in the investigated components of the HPA axis and the SCN in phasic CORT treated groups.  
Per1 and/or Per2 behaved in an oscillatory way to Bmal1 mRNA, displaying antiphasic 
rhythmicity. This has been previously shown (Woodruff, Fardi, and Spencer 2013, unpublished 
data; Girotti et al., 2009) and indicates that there is a functional molecular clock in these cells. 
Moreover, gene expression in the SCN presented with a different phase relationship than the 
components of the HPA axis, which replicated findings in Girotti et al.’s 2009 study. We found 
that CORT treatment did effect the expression of Per1 and Per2 in both the PVN and anterior 
pituitary.   
As expected, due to the lack of GRs in the SCN, Bmal1, Per1, and Per2 gene expression 
showed robust 24 hour rhythms largely unaffected by CORT status. In line with previous reports 
Bmal1 and Per1 displayed an oscillatory rhythm with peaks and troughs in antiphase to each 
other (Girotti et al., 2009). Per2 gene expression peaked between the acrophases of Bmal1 and 
Per1, overlapping with the acrophase of Per1 expression. While statistical difference was found 
among treatment groups, such that the antiphasic CORT treated group was elevated at ZT12 for 
both Bmal1 and Per1 expression, the overlapping confidence intervals of amplitudes likely 
means there is not a functionally significant difference. The oscillatory behavior of these genes is 
support of the presence of an autonomous molecular clock within the SCN.  
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Clock Gene Expression in the PVN: 
Within the PVN clock genes were also rhythmically expressed in all treatment groups. 
Bmal1 and Per1 expression were antiphasic to each other and their SCN counterparts. This may 
be a reflection of the primary source of input to these areas: the SCN is attuned to the light/dark 
cycle and photoperiod; where the PVN is sensitive to activity pattern, nocturnal in rats.  
Interestingly, Per2 expression in vehicle and PM CORT treated groups again peaked at 
the same time as Per1, though the peak is extended, reaching into the dark phase. Antiphasic 
CORT treated rats presented with blunted Per2 expression at ZT 12, peaking solely at ZT 18. 
While removal of CORT did not abolish the rhythms of the clock genes, antiphasic CORT 
treatment caused significant blunting of the amplitudes of Per1 and Per2 expression at ZT 12 
compared to vehicle and PM CORT groups. The antiphasic CORT injection may have caused 
competing input, acting opposite the light/dark cycle input from the SCN, and decreasing the 
acrophase of Per1 expression. This result was expected given the presence of a GRE in its 
promoter region and the ubiquitous expression of GR in the PVN. The functional, highly 
responsive GRE and the blunting influence of antiphasic CORT on Per1 expression in the PVN 
is indicative of its ability to override the entraining effect of photoperiod on clock gene 
expression in the PVN.  
Per2 rhythmicity in PM CORT and Vehicle groups was unaffected by adrenalectomy 
when compared to the adrenal intact rats in Girotti et al.’s 2009 study. AM CORT treated rats 
displayed rhythmic but blunted expression of Per2. The GRE in the promoter region of Per2 has 
been described as continuously occupied, meaning that as long as GR is bound to it, expression 
of PER2 protein is rhythmically expressed (So et al., 2009). It is not clear what the effect of 
adrenalectomy and antiphasic CORT would be on such a mechanism, as the injected CORT 
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dissipates more rapidly in the body than an endogenous peak.  Adrenalectomy has been shown to 
blunt the expression of PER2 protein in the oval nucleus of the bed nucleus of the stria terminalis 
and central nucleus of the amygdala (Amir and Stewart, 2009). However, an effect in mRNA 
expression was found only in the antiphasic CORT treated group of our study. The idea of 
competing inputs, light/dark information from the SCN and the antiphasic CORT injection, may 
be responsible for the blunted rhythm of Per2 mRNA.  
Conversely, a functional GRE in the promoter region of Bmal1 has not been identified, 
and consequently this may be why it was unaffected. As well, the PM CORT treated rats showed 
rhythmic expression which matched rhythmicity of adrenal-intact rats (Woodruff, Fardi & 
Spencer 2013, unpublished data). This CORT profile enables a normal rhythm of Per1 that may 
facilitate the maintenance of Bmal1 expression through the negative influence of its protein 
product.  
Clock Gene Expression in the Anterior Pituitary:  
In the pituitary Bmal1 expression showed a robust 24 hour rhythm in all treatment 
groups, however in Vehicle groups Per1 expression was not rhythmic and Per2 expression was 
extremely blunted at the acrophase. The timing of peaks and troughs of Bmal1 and Per2 of 
rhythmically expressed groups match previous reports (Bur et al., 2010; Girotti et al., 2009) and 
are loosely in phase with the PVN.  
Studies have reported different results regarding Per1: either not significantly rhythmic 
(Girotti et al., 2009) or rhythmic with a peak at ZT 12 (Bur et al., 2010). Where these studies 
characterized baseline clock gene expression and response to restricted feeding, we investigated 
the influence of different CORT profiles. We found that in the pituitary both CORT-treated 
groups Per1 displayed a 24 hour rhythm with an acrophase at ZT 12; however, the vehicle group 
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did not. Given that there was no interaction between CORT status and time of day, it is unlikely 
that there is an effect of effect on Per1 mRNA expression. It may be that CORT’s presence was 
necessary for rhythmicity, but the time of the peak did not matter.  
Per2 expression in the pituitary, despite the statistical rhythmicity, was nearly a flat line, 
with gene expression effectively abolished when compared to other treatment groups. While this 
effect needs to be replicated, the elevated mean expression may suggest that Per2 gene 
expression is up-regulated in response to antiphasic CORT treatment. It is possible that Per2, 
which has a continuously bound GRE (So et al., 2009), is up-regulated due to a lack of 
circulating, endogenous CORT and the influence of a high dosage, antiphasic injection of CORT. 
The rhythm of Per2 expression was robust when CORT was present suggesting that CORT has a 
permissive effect in the pituitary. 
Bmal1 seemed unaffected by CORT status in the anterior pituitary; this may be because 
even in the vehicle group, where Per1 expression was not rhythmic in the pituitary, there were 
still high levels of mRNA and the possibility that PER1 protein was still present and able to 
regulate BMAL1 through negative feedback.  
 The pituitary may be integrating multiple time cues from the periphery and brain, causing 
it to have a rhythm Bur et al. described as flexible (2010). They investigated the effect of 
restricted feeding on clock gene expression in the pituitary. Day time restricted feeding causes a 
shift in CORT expression and activity in rats, in some ways acting as an antiphasic CORT 
treatment. They found that Per2 mRNA expression was blunted in adrenal intact and 
adrenalectomized rats in the anterior pituitary, which suggests presence of CORT may not be 
crucial to synchronizing the oscillator in the gland. Unfortunately, Per1 was not investigated in 
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that experiment. Our findings suggest differently, that CORT may have a permissive effect in the 
anterior pituitary, specifically for expression of Per2, meaning it must be present for rhythmicity.  
As the mammalian anterior pituitary is not innervated, other hormonal factors must come 
into play and enable synchronization (Yoo et al., 2004). The anterior pituitary, which is not 
homogenized tissue, but composed of numerous types of endocrine cells, may require a multi-
input system of synchronization sensitive to multiple entraining factors, such as CORT, 
photoperiod, and may be further coordinated by pituitary hormones in lieu of conflicting input. 
The latter types of coordination and synchronization may be especially important for expression 
of Per1 which does not seem to be primary in the pituitary’s molecular clock, as Per2 and Bmal1 
have been repeatedly shown to express antiphasic rhythms (Girotti et al., 2009; Bur et al., 2010). 
Per1 may also be more sensitive to the light/dark cycle as Bur et al. found mRNA expression 
shifted in response to varied photoperiods (2010. Differential expression in endocrine cell type of 
the anterior pituitary may explain why Girotti et al. did not find Per1 mRNA rhythmic (2009); in 
our experiment, the administered dosage of CORT, 2.5 kg/mg, is higher than the endogenous 
peak and could have entrained the Per1 expression, creating an artificial rhythm. The possibility 
that Per1 is differentially expressed in different endocrine cells of the anterior pituitary requires 
further investigation and may clarify part of the complexity of characterizing clock gene 
expression in the gland.  
Conclusion:  
 In this study we demonstrate that the molecular clocks in various components of the HPA 
axis are differentially responsive to various CORT profiles, influencing specific clock genes and 
that CORT may have a different role in the periphery than the brain. Presence and CORT status 
affects the amplitude and robustness of rhythmicity of clock genes in both the PVN and anterior 
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pituitary. Antiphasic CORT treatment influenced the phase and amplitude of clock genes, 
namely Per1 and Per2 in the PVN. This suggests that CORT may be able to override the 
influence of photoperiod and input from the SCN, at least enough to compete with the input and 
alter molecular functioning. In the anterior pituitary, the absence of CORT, abolished Per2 
mRNA expression, suggesting that CORT may have a permissive role in the clock gene’s 
expression. This means that CORT must be present for there to be rhythmic clock gene 
expression of Per2 in the anterior pituitary but may not be responsible for entraining their 
rhythms. Further exploration into the complex integration of time cues in the pituitary are needed 
to understand the role of CORT on Per1 gene expression, and the possibility of multiple time 
cues being integrated.   
Dysregulation of normal HPA axis functioning has been linked with psychiatric disorders 
(Pariante and Lightman, 2008). Depending on the kind of disruption or disorder, 
hypercortisolemia, seen in Major Depressive Disorder (Ahiara et al., 2007; Pariante & Miller, 
2001), or hypocortisolemia, observed in Depersonalization Disorder and Posttraumatic Stress 
Disorder (Heim et al., 2000; Simeon et al., 2001; Schuder, 2006). Both profiles have the 
potential to created metabolic and immune disorders given the normal role CORT in the body. 
Phase shifts in CORT have been implicated in manic-depressive disorders (Wehr et al., 1980). 
Given CORT’s role in regulating and entraining molecular clocks, disruption in the circadian and 
HPA axis systems and interactions may cause dysynchronization in molecular clocks in the 
periphery and non-SCN brain region. People who experience jet lag often and shift workers 
experience internal desynchrony and are at increased for depression and cardiovascular disorders 
(Penev et al., 1998; Knutsson, 2003). In particular the effect of antiphasic CORT which impacted 
Per1 and Per2 gene expression PVN, caused variation in clock gene expression in the pituitary, 
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and potentially disengaging the gland from the PVN. Characterizing and understanding the 
mechanisms underlying regulation of the molecular clocks in the HPA axis and the wide spread 
consequences of disruption are crucial steps to developing effective treatments for these 
disorders.   
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